Devyser Diagnostics AB (DVYSR) — Cash Flow Reinvestment Rate
Devyser Diagnostics AB (DVYSR) has a Cash Flow Reinvestment Rate of 0.02x as of March 2026, reinvesting Skr300.00K (capex Skr300.00K ) from operating cash flow of Skr12.10 Million. Explore how much does Devyser Diagnostics AB reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Devyser Diagnostics AB Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Devyser Diagnostics AB across 4 annual periods. Also explore Devyser Diagnostics AB total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Devyser Diagnostics AB (2018–2025)
Year-by-year capital reinvestment analysis for Devyser Diagnostics AB. For live market cap and broader valuation context, see market value of Devyser Diagnostics AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | Skr2.00 Million | Skr8.20 Million | Skr1.50 Million | ▼ -98.1% |
| 2020 | 12.96x | Skr8.13 Million | Skr627.00K | Skr3.41 Million | ▲ +1936.5% |
| 2019 | 0.64x | Skr9.31 Million | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr5.06 Million | Skr6.02 Million | Skr5.06 Million | — |